Healthcare provider profile · identity verified

Yousaf Jalil, M.D.

Internal Medicine · SAINT CHARLES, MO · NPI 1629384136

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	1000	301
Amlodipine Besylate	Amlodipine Besylate	696	202
Losartan Potassium	Losartan Potassium	407	121
Alprazolam	Alprazolam	403	101
Levothyroxine Sodium	Levothyroxine Sodium	401	104
Lisinopril	Lisinopril	327	113
Tramadol Hcl	Tramadol Hcl	299	81
Pantoprazole Sodium	Pantoprazole Sodium	297	90
Omeprazole	Omeprazole	296	87
Glimepiride	Glimepiride	271	79
Metformin Hcl	Metformin Hcl	244	73
Simvastatin	Simvastatin	221	74
Metoprolol Succinate	Metoprolol Succinate	214	65
Albuterol Sulfate Hfa	Albuterol Sulfate	204	63
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	198	55
Hydrochlorothiazide	Hydrochlorothiazide	194	60
Pravastatin Sodium	Pravastatin Sodium	190	55
Tizanidine Hcl	Tizanidine Hcl	183	59
Arexvy	Rsvpref3 Antigen/As01e/Pf	181	179
Tamsulosin Hcl	Tamsulosin Hcl	167	55
Allopurinol	Allopurinol	159	48
Gabapentin	Gabapentin	159	53
Rosuvastatin Calcium	Rosuvastatin Calcium	149	50
Furosemide	Furosemide	140	60
Atenolol	Atenolol	125	38
Clopidogrel	Clopidogrel Bisulfate	123	31
Lorazepam	Lorazepam	121	24
Zolpidem Tartrate	Zolpidem Tartrate	113	24
Famotidine	Famotidine	108	36
Januvia	Sitagliptin Phosphate	107	28
Metoprolol Tartrate	Metoprolol Tartrate	107	34
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	105	25
Fluticasone Propionate	Fluticasone Propionate	102	46
Escitalopram Oxalate	Escitalopram Oxalate	99	32
Eliquis	Apixaban	98	22
Carvedilol	Carvedilol	96	28
Sertraline Hcl	Sertraline Hcl	94	30
Trazodone Hcl	Trazodone Hcl	88	26
Metformin Hcl Er	Metformin Hcl	85	25
Duloxetine Hcl	Duloxetine Hcl	78	21
Finasteride	Finasteride	78	24
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	77	25
Citalopram Hbr	Citalopram Hydrobromide	71	22
Potassium Chloride	Potassium Chloride	71	26
Lovastatin	Lovastatin	63	20
Ozempic	Semaglutide	63	17
Montelukast Sodium	Montelukast Sodium	58	13
Warfarin Sodium	Warfarin Sodium	57	17
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	53	16
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	52	15
Diazepam	Diazepam	47	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	47	13
Spironolactone	Spironolactone	47	12
Pregabalin	Pregabalin	46	suppressed
Bupropion Xl	Bupropion Hcl	44	16
Fenofibrate	Fenofibrate Nanocrystallized	43	suppressed
Meloxicam	Meloxicam	42	14
Hydralazine Hcl	Hydralazine Hcl	40	19
Donepezil Hcl	Donepezil Hcl	39	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	39	36
Paroxetine Hcl	Paroxetine Hcl	39	13
Mirtazapine	Mirtazapine	37	suppressed
Ezetimibe	Ezetimibe	36	13
Atenolol-Chlorthalidone	Atenolol/Chlorthalidone	35	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	33	27
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	30	suppressed
Primidone	Primidone	30	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	30	suppressed
Meclizine Hcl	Meclizine Hcl	27	11
Triamcinolone Acetonide	Triamcinolone Acetonide	27	17
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	26	suppressed
Memantine Hcl	Memantine Hcl	26	suppressed
Ropinirole Hcl	Ropinirole Hcl	26	suppressed
Temazepam	Temazepam	26	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	25	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	25	12
Venlafaxine Hcl Er	Venlafaxine Hcl	25	suppressed
Fenofibrate	Fenofibrate	24	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	24	suppressed
Torsemide	Torsemide	24	suppressed
Azelastine Hcl	Azelastine Hcl	23	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	23	suppressed
Methylprednisolone	Methylprednisolone	23	20
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	23	18
Nortriptyline Hcl	Nortriptyline Hcl	23	suppressed
Abrysvo	Rsv Vacc, Pref A And Pref B/Pf	22	22
Celecoxib	Celecoxib	22	suppressed
Chlordiazepoxide Hcl	Chlordiazepoxide Hcl	22	suppressed
Farxiga	Dapagliflozin Propanediol	22	suppressed
Xarelto	Rivaroxaban	22	suppressed
Chlorthalidone	Chlorthalidone	21	suppressed
Diclofenac Sodium	Diclofenac Sodium	21	suppressed
Klor-Con M10	Potassium Chloride	21	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	21	suppressed
Zolpidem Tartrate Er	Zolpidem Tartrate	21	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	20	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	20	13
Acetaminophen-Codeine	Acetaminophen With Codeine	19	suppressed
Azithromycin	Azithromycin	19	19
Enalapril Maleate	Enalapril Maleate	19	suppressed
Glipizide	Glipizide	19	suppressed
Glipizide Er	Glipizide	19	suppressed
Tramadol Hcl-Acetaminophen	Tramadol Hcl/Acetaminophen	19	suppressed
Clonazepam	Clonazepam	18	suppressed
Folic Acid	Folic Acid	18	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	18	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	18	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	18	suppressed
Valsartan	Valsartan	18	suppressed
Buspirone Hcl	Buspirone Hcl	17	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	17	suppressed
Ketoconazole	Ketoconazole	17	suppressed
Levetiracetam	Levetiracetam	17	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	17	17
Propranolol Hcl	Propranolol Hcl	17	suppressed
Sildenafil Citrate	Sildenafil Citrate	17	suppressed
Valacyclovir	Valacyclovir Hcl	17	suppressed
Vancomycin Hcl	Vancomycin Hcl	17	suppressed
Cephalexin	Cephalexin	16	16
Tobramycin	Tobramycin	16	suppressed
Alendronate Sodium	Alendronate Sodium	15	suppressed
Ventolin Hfa	Albuterol Sulfate	15	suppressed
Amiodarone Hcl	Amiodarone Hcl	14	suppressed
Carisoprodol	Carisoprodol	14	suppressed
Ciclopirox	Ciclopirox	14	suppressed
Ciclopirox	Ciclopirox Olamine	14	suppressed
Jardiance	Empagliflozin	14	suppressed
Acyclovir	Acyclovir	13	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	13	suppressed
Prednisone	Prednisone	13	12
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	13	suppressed
Baclofen	Baclofen	12	suppressed
Oxazepam	Oxazepam	12	suppressed
Spiriva Respimat	Tiotropium Bromide	12	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	12	suppressed
Topiramate	Topiramate	12	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	11	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	11	suppressed
Breo Ellipta	Fluticasone/Vilanterol	11	suppressed
Chlorpromazine Hcl	Chlorpromazine Hcl	11	suppressed
Humalog Kwikpen U-100	Insulin Lispro	11	suppressed
Myrbetriq	Mirabegron	11	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	11	suppressed
Nifedipine Er	Nifedipine	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error